The novel treatment of the medication represents a major development in the management of type 2 diabetes. Unlike existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide143438.blogunteer.com/40676702/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment